Wencong Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Wencong Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chuanbo Ding
School of Traditional Chinese Medicine, Jilin Agriculture Science and Technology College, Jilin 132101, China
1 shared publication - Lina Ma
College of Traditional Chinese Medicine, Jilin Agriculture Science and Technology College, Jilin 132101, China
1 shared publication - Ning Wang
School of Resources and Environment, Jilin Agricultural University, Changchun 130118, China
1 shared publication - Qiteng Ding
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China
1 shared publication - Shuang Ma
College of Food and Pharmaceutical Engineering, Wuzhou University, Wuzhou 543002, China
1 shared publication - Ting Zhao
College of Traditional Chinese Medicine, Jilin Agriculture Science and Technology College, Jilin 132101, China
1 shared publication
Latest Publications
- Open Access
Synthesis of Taxifolin-Loaded Polydopamine for Chemo-Photothermal-Synergistic Therapy of Ovarian Cancer
Chemotherapy is a well-established method for treating cancer, but it has limited effectiveness due to its high dosage and harmful side effects. To address this issue, researchers have explored the use of photothermal agent nanoparticles as carriers for precise drug release in vivo. In this study, three different sizes of polydopamine nanoparticles (PDA–1, PDA–2, and PDA–3) were synthesized and evaluated. PDA–2 was selected for its optimal size, encapsulation rate, and drug loading rate. The release of the drug from PDA–2@TAX was tested at different pH and NIR laser irradiation levels. The results showed that PDA–2@TAX released more readily in an acidic environment and exhibited a high photothermal conversion efficiency when exposed to an 808 nm laser. In vitro experiments on ovarian cancer cells demonstrated that PDA–2@TAX effectively inhibited cell proliferation, highlighting its potential for synergistic chemotherapy-photothermal treatment.
Open AccessSynthesis of Taxifolin-Loaded Polydopamine for Chemo-Photothermal-Synergistic Therapy of Ovarian Cancer
Chemotherapy is a well-established method for treating cancer, but it has limited effectiveness due to its high dosage and harmful side effects. To address this issue, researchers have explored the use of photothermal agent nanoparticles as carriers for precise drug release in vivo. In this study, three different sizes of polydopamine nanoparticles (PDA–1, PDA–2, and PDA–3) were synthesized and evaluated. PDA–2 was selected for its optimal size, encapsulation rate, and drug loading rate. The release of the drug from PDA–2@TAX was tested at different pH and NIR laser irradiation levels. The results showed that PDA–2@TAX released more readily in an acidic environment and exhibited a high photothermal conversion efficiency when exposed to an 808 nm laser. In vitro experiments on ovarian cancer cells demonstrated that PDA–2@TAX effectively inhibited cell proliferation, highlighting its potential for synergistic chemotherapy-photothermal treatment.